IP Library Granted Patent US 10,806,630
Granted Patent B2
US 10,806,630 · App. 16/861,472 · Granted Oct 20, 2020

Injection device for subretinal delivery of therapeutic agent

Inventors: Daniel W. Price (Loveland, OH); Brendan J. Oberkircher (Cincinnati, OH); James G. Lee (Raynham, MA); Clinton Denlinger (Cincinnati, OH); Daniel J. Prenger (Loveland, OH); Geoffrey King (Cincinnati, OH); Scott Uhland (San Jose, CA); Mark C. Tsai (Chalfont, PA); Michael F. Keane (Downington, PA); Isaac J. Khan (Bridgewater, NJ); Benjamin L. Ko (Cincinnati, OH); Thomas E. Meyer (Philadelphia, PA); Denis P. Turner (San Clemente, CA)
Assignee: GYROSCOPE THERAPEUTICS LIMITED
A61F9/0026A61B46/23A61B50/30A61F9/0008A61F9/0017A61M25/02A61B2046/234A61B2050/314A61M2025/0213A61M2025/0266
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,806,630
App. No.
16/861,472
Granted
Oct 20, 2020
Kind
B2
Abstract

An apparatus includes a pad assembly, an injector assembly, an injector driver, and a fluid source. The pad assembly is sized and configured to be placed on a forehead of a patient. The injector assembly includes a body, a flexible cannula, and a needle. The body is configured to be removably secured to the pad assembly. The cannula is sized to be inserted through an incision in an eye of a patient. The needle is slidably disposed in the cannula. The injector driver is operable to drive the needle longitudinally relative to the flexible cannula. The fluid source assembly is in fluid communication with the needle.

Claims (25)

1. An apparatus, comprising:

(a) an injector assembly, wherein the injector assembly comprises:

(i) a body,

(ii) a flexible cannula extending distally from the body, wherein the flexible cannula is sized to be inserted through an incision in an eye of a patient, and

(iii) a needle slidably disposed in the flexible cannula;

(b) an injector driver, wherein the injector driver is operable to drive the needle longitudinally relative to the flexible cannula;

(c) a fluid source assembly in fluid communication with the needle; and

(d) a magnetic pad assembly, wherein the magnetic pad assembly is sized and configured to be placed on a forehead of the patient, and the magnetic pad assembly includes an adhesive;

wherein the body of the injector assembly is configured to be removably secured to the magnetic pad assembly;

wherein the injector assembly further comprises a magnet, wherein the magnet is configured to removably secure the body to the magnetic pad assembly via magnetic attraction, where the magnet is held in a stationary position relative to the body;

wherein the injector driver is operable to drive the needle longitudinally relative to the magnet.

2. The apparatus of claim 1 , wherein the injector driver is integrated into the body.

3. The apparatus of claim 1 , wherein the injector driver is remotely coupled with the injector assembly via a flexible drive cable.

4. The apparatus of claim 1 , wherein the magnetic pad assembly comprises at least one ferrous element.

5. The apparatus of claim 1 , wherein the injector assembly further includes a needle actuator positioned in the body, wherein the needle is fixedly secured to the needle actuator, wherein the needle actuator is configured to translate relative to the body to thereby drive the needle longitudinally relative to the flexible cannula.

6. The apparatus of claim 5 , wherein the needle actuator further includes at least two fluid inputs in fluid communication with the needle, such that the needle actuator is configured to form a manifold.

7. The apparatus of claim 1 , wherein the injector driver comprises a rotary knob, wherein the rotary knob is rotatable to drive the needle longitudinally relative to the flexible cannula.

8. The apparatus of claim 7 , wherein the rotary knob includes a spiral cam feature, wherein the spiral cam feature is configured to cooperate with another needle drive element to thereby drive the needle longitudinally in response to rotary movement of the rotary knob.

9. The apparatus of claim 7 , wherein the injector driver further comprises a translatable member having a cam follower coupled with the spiral cam feature, wherein the cam follower and the spiral cam feature are configured to cooperate with each other to thereby convert rotary movement of the rotary knob into longitudinal movement of the needle.

10. The apparatus of claim 1 , wherein the injector driver further comprises a first user input feature, wherein the first user input feature is operable to provide delivery of a therapeutic agent via the needle.

11. The apparatus of claim 10 , wherein the first user input feature comprises a pushbutton.

12. The apparatus of claim 1 , wherein the injector driver further comprises a bleb fluid delivery input feature, wherein the bleb fluid delivery input feature is operable to provide delivery of a bleb fluid via the needle.

13. The apparatus of claim 12 , wherein the bleb fluid delivery input feature comprises a sensor, wherein the sensor is configured to sense a position of the needle in relation to the body, wherein the sensor comprises a linear potentiometer.

14. The apparatus of claim 1 , wherein the fluid source assembly comprises a syringe actuation cassette, wherein the syringe actuation cassette is configured to provide automatic actuation of a syringe to thereby expel contents of the syringe through the needle.

15. The apparatus of claim 1 , wherein the fluid source assembly further includes a thawing module, wherein the thawing module is operable to thaw a volume of frozen therapeutic agent.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 2, 2024
From: GYROSCOPE THERAPEUTICS LIMITED
To: F. HOFFMANN-LA ROCHE AG
Reel/Frame 069091/0527 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 2, 2024
From: F. HOFFMANN-LA ROCHE AG
To: GENENTECH, INC.
Reel/Frame 069097/0746 →
CORRECTIVE ASSIGNMENT TO CORRECT THE THE ASSIGNOR SHOULD READ "ORBIT BIOMEDICAL LIMITED" PREVIOUSLY RECORDED ON REEL 053762 FRAME 0437. ASSIGNOR(S) HEREBY CONFIRMS THE THE ORIGINAL READ "ORBIT BIOMEDICAL LIMTED". Recorded Sep 23, 2020
From: ORBIT BIOMEDICAL LIMITED
To: GYROSCOPE THERAPEUTICS LIMITED
Reel/Frame 053856/0539 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 14, 2020
From: ORBIT BIOMEDICAL LIMTED
To: GYROSCOPE THERAPEUTICS LIMITED
Reel/Frame 053762/0437 →
Continuity (3)
Continuation 15609457 · May 31, 2017
Provisional Application 62351628 · Jun 17, 2016
Related Publication 20200297531A1 · Sep 24, 2020
Cited By (5)
US 1,116,103 US 1,120,314 US 12,274,865 US 12,649,031 US 12,691,227